By overexpressing or knocking down S1P receptor expression in glioma cells, Lepley et al. showed that the S1P2 receptor mediates inhibition of migration, while S1P1 mediates enhanced glioma cell migration in response to S1P [3]. Here, MBTPS1 is linked to central nervous system cancer.